The Fund seeks to generate long term capital appreciation by investing in a diversified portfolio of equity & equity related instruments across large cap, mid cap, small cap stocks. Disclaimer: There is no assurance or guarantee that the objectives of the scheme will be realised. This product is suitable for investors who are seeking...

The primary investment objective of the scheme is to seek to achieve capital appreciation in the long-term by primarily investing in a welldiversified portfolio of value stocks. The AMC will have the discretion to completely or partially invest in any of the type of securities stated above with a view to maximize the returns or on defensive

The investment objective of the scheme is to generate long term capital appreciation for investors from a portfolio of equity and equity related securities selected based on quant theme. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. This product is suitable for investors

The scheme endeavours to provide regular income and capital growth with limited interest rate risk to the investors through investments in a portfolio comprising of debt instruments maturing on or before the maturity of the scheme. There is no assurance or guarantee that the scheme’s objective will be achieved. The product is

To generate returns that are commensurate (before fees and expenses) with the performance of the NIFTY Next 50 Index TRI (Underlying Index), subject to tracking errors. There is no assurance that the investment objective of the scheme will be realized. The product is suitable for investors who are seeking returns that are...

The investment objective of the scheme is to provide capital appreciation/ income to the investors from a dynamic mix of equity, debt and money market instruments. The scheme seeks to reduce the volatility by diversifying the assets across equity, debt and money market instruments. However, there is no assurance or guarantee that

The investment objective of the scheme is to provide returns that before expenses, closely correspond to the total returns of securities as represented by Nifty Information Technology TRI, subject to tracking errors. However, the performance of scheme may differ from that of the underlying index due to tracking error. The scheme

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved. The product is suitable for

The investment objective of the scheme is to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved. This product is suitable for investors who are

The scheme seeks to provide returns that, before expenses, closely correspond to the total return of the underlying index (NIFTY 50 Equal Weight Index), subject to tracking errors. There is no assurance that the investment objective of the scheme will be realized. The product is suitable for investors who are seeking long-term capital